Different mechanisms in Hh signaling activation may be attributed to the heterogeneity of HCC, and Hh molecules, including SMO and GLIs, are considered to be targets for molecular intervention, such as GDC-0449 and LDE225 for SMO, and arsenic trioxide (ATO) or GANT61 for GLIs [46]. Here, SMO is linked to hepatocellular carcinoma.